In nontumorigenic mammary epithelial cells (EpH4), transforming growth factor-b (TGFb1) causes cell cycle arrest/apoptosis, but induces epitheliomesenchymal transition (EMT) in Ha-Ras-transformed EpH4 cells (EpRas). EMT is closely correlated with late-stage tumor progression and results in fibroblastic, migratory cells displaying a mesenchymal gene expression program (FibRas). EpRas and FibRas cells showed strongly increased cell substrate adhesion to fibronectin, collagens I/IV and laminin 1. Furthermore, Ras transformation caused enhanced or de-novo expression of the integrin subunits b1, a2 and a3, or a5 and a6, respectively, the latter subunits being even more strongly expressed in FibRas cells. Importantly, polarized EpRas cells expressed integrin subunits b1 and a6 at distinct (apical and lateral) membrane domains, while FibRas cells coexpressed these integrins and a5 at the entire plasma membrane. During EMT, EpRas cells formed an a5b1 complex and deposited its ligand fibronectin into the extracellular matrix. Function-blocking a5 antibodies attenuated migration, and caused massive apoptosis in EpRas cells undergoing TGFb1-induced EMT in collagen gels, but failed to affect EpRas-or FibRas-derived structures. We conclude that functional a5b1 integrin is centrally implicated in EMT induction. Importantly, FibRas cells also failed to deposit the a6b4 ligand laminin 5, suggesting that a6b4 is no longer functional after EMT and replaced by mesenchymal integrins such as a5b1.
Introduction
During carcinoma progression, epithelial tumor cells acquire the ability to digest their underlying basement membrane, break existing attachments, extend pseudopodia and survive/migrate within the interstitial stroma, gaining access to blood vessels and distant tissues during metastasis. Integrins that bind to various extracellular matrix (ECM) components critically regulate cell adhesion to basement membranes during the process of tumor cell invasion. Integrins link the ECM to intracellular structures, and like growth factor receptors, transmit signals from the outside of the cell into its interior (outside-in signaling; Hood and Cheresh, 2002) . Hence, they are influencing central cellular properties, such as proliferation, differentiation and apoptosis (Schwartz, 1997; Howe et al., 1998) . Signaling events also impinge upon integrin function by regulating the ability of integrins to bind their ligands, a process termed inside-out signaling (Hood and Cheresh, 2002) , or integrin activation. Integrin activation helps to determine the nature of cellular responses to ECM, influencing decisions such as cell migration or whether a cell will remain stationary and differentiate (Palecek et al., 1996) .
Integrins are heterodimeric transmembrane proteins that consist of a and b subunits (for reviews see van der Flier and Sonnenberg, 2001; Hynes, 2002) . There are 18 known a subunits and eight b subunits that combine into some 25 different integrins. Integrins are expressed in a cell-type-and differentiation-stage-specific manner. One specific group of integrins is associated with migration and proliferation in various cell types. These so-called 'emergency integrins' include a5b1, avb5 and avb6 (Sheppard, 1996) . The same integrins are also significantly upregulated in the keratinocytes of healing wounds (Zambruno et al., 1995) .
Carcinoma cells frequently lose certain epithelial characteristics and gain properties of migrating cells when progressing to a more malignant state. Several proteins constituting junctional complexes of epithelial cells, such as E-cadherin and the catenins, and also components of growth factor-induced signal cascades like receptor tyrosine kinases and various phosphatases, may be altered in expression or mutated during cancer progression (Birchmeier et al., 1996) . In certain cases, tumor cell dedifferentiation involves an epitheliomesenchymal transition (EMT), which can be caused by cooperation between transforming growth factor-b (TGFb1) and oncogenic Ras (Oft et al., 1998) . During EMT, mammary epithelial cells (EpH4) transformed by Ras (EpRas) acquire a fibroblastoid, migratory phenotype, characterized by loss of epithelial polarity and epithelial marker proteins, and de novo expression of mesenchymal markers. The converted, spindle-shaped cells (FibRas) produce high levels of TGFb1 in an autocrine manner, which in turn stabilizes the mesenchymal phenotype (Oft et al., 1996) . EMT of EpRas cells required cooperation between TGFb1 signaling and hyperactive ERK/MAPK signaling, activated by oncogenes such as Ha-Ras or the constitutively active EGF-receptor 2, Neu (Oft et al., 1998; Janda et al., 2002; A Pacher and H Beug, unpublished) . The same cooperation is also important in tumor progression and metastasis (for a review see Thiery, 2002; Gru¨nert et al., 2003) . While changes in integrin expression and function during loss of polarity and local invasion of epithelial tumor cells are relatively well studied (for a review see Hood and Cheresh, 2002) , much less is known about respective changes during late-stage tumor progression and metastasis mirrored by EMT.
The aim of this study was to gain further insight into how surface expression of the integrins a2b1, a3b1, a5b1 and a6b1 and adhesion to their ligands, that is, distinct ECM proteins, are modulated during the process of TGFb1-induced EMT. We show here that Ras transformation strongly enhances adhesion of EpRas cells to fibronectin, collagens I/IV and laminin 1 when compared to EpH4 cells. Accordingly, surface expression of the integrin subunits b1, a2, a3, a5 and a6 was enhanced on EpRas cells. Especially the integrin subunit a5 was highly upregulated in EpRas cells but was located at the lateral cell membrane. The mesenchymal FibRas cells further upregulated the a5 and a6 integrin subunits, which both colocalized with b1 integrin subunits. This enables the formation of a functional a5b1 integrin heterodimer, which is paralleled by increased matrix deposition of fibronectin. Blocking a5b1 integrin function did not affect organotypic structure formation of EpRas cells but prevented TGFb1-induced EMT of EpRas cells in collagen gels, causing apoptosis instead. Furthermore, the enhanced migration of FibRas cells could be attenuated by a5-function-blocking antibody. This suggests that the mesenchymal integrin a5b1 is required for migration and protection from apoptosis during EMT but is not necessary to maintain the fibroblastoid phenotype after EMT.
FibRas cells also lost the ability to deposit laminin 5, perhaps corresponding to the fact that these cells did no longer require a basement membrane and cell adhesion via hemidesmosomes. Supporting our findings, loss of laminin 5 expression is also observed in invasive breast carcinomas and dedifferentiated mammary carcinoma cells (Henning et al., 1999; Miller et al., 2001) . Our results suggest that altered expression and activation of laminin receptors like a6b4 during migration and local invasion of epithelial tumor cells (Rabinovitz and Mercurio, 1997; O'Connor et al., 1998) might not apply for dedifferentiated 'mesenchymal' cells after EMT.
Instead, these seem to utilize fibronectin receptors like a5b1 to migrate in nonepithelial ECMs during (distant) metastasis (Putz et al., 1999; Reeves et al., 2001) .
Results

Activated Ras modifies adhesion to the ECM
Cell matrix adhesion assays were performed to investigate the effects of both Ras transformation and EMT on cell-substrate adhesion of EpRas and FibRas cells. Cells were plated for 1 h on dishes coated with purified ECM components, such as collagens I/IV, fibronectin, and laminins 1 and 5, using BSA as a control. Parental, nontumorigenic EpH4 cells did almost not adhere to fibronectin, collagens I/IV or laminin 1, while adhesion to laminin 5 was extremely efficient (Figure 1) . Surprisingly, EpRas cells adhered much stronger to all ECM proteins tested. Adhesion to fibronectin, the two collagen types and laminin 1 was seven-to 10-fold enhanced ( Figure 1 ). In contrast, FibRas cells bound to fibronectin, collagen I and laminin 1 with a somewhat reduced efficiency, while adhesion to collagen IV was further increased (Figure 1 ). Thus, Ras transformation significantly increased cell-substrate adhesion of EpH4 mouse mammary epithelial cells.
Integrin subunits a5 and a6 are induced during Ras transformation and EMT To address whether altered cell adhesion of EpRas and FibRas could be correlated with alterations in integrin expression, we investigated both total and cell surface Western blot analysis revealed that integrin subunits b1, a2 and a3 were clearly upregulated in cell lysates of EpRas cells (as compared to parental EpH4 cells), but again somewhat reduced in FibRas cells (Figure 2a ). In contrast, a5 and a6 chains were E3-fold upregulated in EpRas cells, while their expression was further enhanced (about six-fold) in FibRas cells.
Subsequently, surface expression of the various integrins was measured by cell surface biotinylation, followed by immunoprecipitation with anti-integrin antibodies and detection of the biotinylated integrins with streptavidin-horse radish peroxidase. As depicted in Figure 2b , b1, a2 and a3 were expressed on parental EpH4 cells, whereas low amounts of a5 and hardly any a6 was detectable on their surface (Figure 2b ). Ras transformation significantly enhanced or newly induced surface expression of the monomers b1, a2, a5 and a6. Strikingly, the migratory FibRas cells showed even further upregulation of subunit a5 and a6 surface expression ( Figure 2b ). FACS analysis for a5 confirmed that these expression changes occurred on all cells in a similar manner (Figure 2c ). These results agree with the increased adhesion of EpRas cells to various ECM proteins and show that additional integrin subunits became more pronounced or de novo expressed during EMT.
To determine which of these changes were specific for EMT, we employed EpH4 cells expressing two different Ras effector mutants. The V12S35 mutant hyperactivates the MAPK pathway and causes EMT in cooperation with TGFb1 (Janda et al., 2002) . In contrast, the V12C40 mutant selectively activates the PI3K pathway and causes a less severe change of epithelial plasticity, that is, loss of epithelial polarity and induction of migration, but no sustained changes in epithelial or mesenchymal markers (referred to as 'scattering'; Janda et al., 2002; Gru¨nert et al., 2003) . As depicted in Figure 2d , surface expression of a2, a3 and b1 was comparable in parental EpRas and in the V12S35 and V12C40 mutants. In contrast, surface expression of a5 and a6 was high in EpRas and V12S35 cells but reduced in the V12C40-expressing cells, which do not undergo EMT (Figure 2d ). For a5, these results could be confirmed by immunofluorescence (data not shown). These data indicate that the hyperactive ERK/MAPK pathway, centrally implicated in the induction of EMT, is involved in the upregulation of integrin subunits like a5 and a6 at the cell surface.
Ras transformation modulates the polarized expression of integrins
In comparison to EpH4 cells, EpRas cells acquire a 'plastic epithelium' phenotype characterized by a higher flexibility of cell/cell contacts but with unaltered epithelial polarity (Gru¨nert et al., 2003) . In contrast, FibRas cells have lost both epithelial polarity and E-cadherin expression, which prevents the formation of tight epithelial cell/cell contacts. We therefore analysed the subcellular distribution of the various integrin subunits, and their localization at the apical and basolateral plasma membrane, employing immunohistochemistry and confocal microscopy ( Figure 3a) . Surprisingly, cultures of nontumorigenic EpH4 cells expressed the b1 chain predominantly at the apical plasma membrane, while its potential heterodimerization partners a5 and a6 were mainly detected in the cytoplasm or weakly expressed, respectively ( Figure 3a , left panels). Thus, these integrin a and b subunits may be locally separated on EpH4, unable to form functional dimers. This might explain the moderate adhesion of EpH4 cells to collagens I/IV, fibronectin and laminin 1.
Upon Ras transformation, a6 was strongly upregulated (compare Figure 2 and Figure 3a , lower middle panels) and became strictly laterally expressed in all EpRas clones investigated ( Figure 3a , lower middle panel). In contrast, the b1 subunit was expressed on the entire cell surface (Figure 3 , upper middle panel), suggesting that Ras transformation altered the polar apical expression of the b1 subunit, which agrees with the previously observed increase in epithelial plasticity As expected, no polarized expression of the subunits b1, a5 and a6 could be observed in converted fibroblastoid FibRas cells ( Figure 3a , right panels; also true for a1 and a2, data not shown). Importantly, and in contrast to EpH4 and EpRas cells, FibRas cells showed a nonpolarized, plasma-membrane distribution of the a5 subunit, which was very similar to the distribution of the b1 subunit ( Figure 3a , upper and central right panel).
These findings suggest that FibRas cells can assemble a functional fibronectin receptor a5b1, which may be implicated in cell migration and which is not usually expressed by differentiated mammary epithelial cells (see also Figure 6a ). FibRas cells also showed enhanced expression of the a6b1 integrin heterodimer, as shown by IP/Western analysis ( Figure 3b ). Interestingly, we found that a6b4 integrin heterodimers are formed in a density-dependent manner in EpH4 cells and are even enhanced by activated Ras in EpRas cells as compared with EpH4, but are reduced in the migratory FibRas cells (data not shown).
Effects of TGFb1 on integrin expression and migration behavior during EMT
To study whether TGFb1 would affect integrin expression and migration of the three cell types investigated, we checked the effect of TGFb1 on in vitro wound closure of EpH4, EpRas and FibRas cells. While the cytokine had no detectable short-term (up to 6 h) effect on EpH4 cells, it weakly stimulated movement of the tight EpRas monolayer into the wound (Figure 4a ). Converted FibRas cells, however, could be induced by TGFb1 to close the wound within 5-6 h ( Figure 4 ). Since a5b1 integrin is strongly upregulated in FibRas cells after completing EMT, which also show enhanced migration ( Figures 3 and 4 and see below), we also asked whether blocking the function of a5b1 integrin might interfere with migration of FibRas cells. For this, a wound closure assay was performed using FibRas cells incubated or not incubated with a function-blocking a5 subunit antibody, in the absence or presence of TGFb1. We found that the a5 antibody clearly decreased migration of FibRas cells in this assay, regardless of the presence or absence of TGFb1 (Figure 4b ).
Based on these findings, we studied the effect of TGFb1 on the modulation of integrin expression and exposure at the cell surface during distinct stages of EMT in more detail. EpRas cells were exposed to recombinant TGFb1 for 4, 6, 8 and 30 days (Figure 5a ). Within 3-4 days, TGFb1 promoted a clear EMT in a substantial proportion of EpRas cells. As already revealed by the analysis of total cell lysates, this change in phenotype was paralleled by the expression of the a5 chain, whereas expression levels of the integrin subunits b1, a2 and a3 was similar, weakly increasing after 6-8 days and slightly decreasing thereafter (Figure 5a , upper panel). In addition, TGFb1 applied for 6 and 12 h also stimulated the expression of the a6 integrin subunit (Figure 5a , lower panel).
Biotin surface labeling revealed a substantial increase of a5 surface expression after incubation with TGFb1 for 48 h, suggesting this to be an early process during EMT (Figure 5b ). Consistently, TGFb1 treatment caused efficient induction of fibronectin production and its deposition on the surface of EpRas cells within 48 h, while fibronectin was hardly deposited by the same cells not treated with TGFb1 (Figure 5c ; see Maschler et al., 2004) . These findings suggest that a5b1 acts as a major fibronectin receptor during the progress of EMT, antibodies to integrin subunits b1 (top panels), a5 (central panels) and a6 (bottom panels). They were then analysed for expression of these integrins by conventional fluorescence microscopy (upper subpanels) and confocal microscopy showing virtual sections through the cell layers via XZ images (lower subpanels). In combination, these imaging techniques allow discrimination between predominantly cytoplasmic (a5 in EpH4/EpRas cells), polarized apical (b1 in sparse EpH4) or lateral expression (a5 in EpRas cells) and nonpolar, delocalized plasma-membrane expression (b1, a5 and a6 in FibRas cells). (b) a6b1 integrin heterodimers were detected by IP-Western analysis, first immunoprecipitating the a6 subunit from total cell lysates of EpH4, EpRas and FibRas cells, and then detecting the co-precipitated b1 subunit by Western blot, using respective polyclonal a6 and b1 antibodies. Western blot analysis of the free a6 subunit is shown as a control Ha-Ras induction of integrins S Maschler et al not excluding that fibronectin receptors other than a5b1 are active in these cells. Furthermore, TGFb1 addition caused the loss of polarized integrin expression in the EpRas clones. The a6 subunit showed strictly lateral expression before TGFb1 addition, but was expressed at the entire cell surface 48 h after the addition of TGFb1 (Figure 5d ).
These findings suggest that TGFb1 not only triggers surface expression of the a5b1 fibronectin receptor but also induces relatively high and depolarized expression of the a6 subunit. This might favor migration of cells within the ECM (through a6b1), rather than maintaining them in a fixed position on a basement membrane (mediated for instance by a6b4).
A functional a5b1 fibronectin receptor is required for cell survival during EMT As shown in Figure 5 , an early event during TGFbinduced EMT is the onset of fibronectin synthesis and its deposition as fibrils. Formation of fibronectin fibrils requires the presence of fibronectin receptors such as a5b1 (Schwarzbauer and Sechler, 1999) . Accordingly, surface expression of a5 was upregulated within 48 h after treating EpRas cells with TGFb1. To test whether a5b1 heterodimers were indeed formed at the onset of EMT, IP-Western analysis was performed. Immunoprecipitation with b1 antibodies, followed by detection of the a5b1 heterodimer with a5 antibodies in Western blots, showed that parental EpH4 cells express very little a5b1. EpRas cells showed increased but still low levels of a5b1, while FibRas cells showed high levels of the a5b1 complex (Figure 6a ). The data shown in Figure 5a suggest that a5b1 upregulation occurs early during EMT.
To test whether expression of functional a5b1 integrin was essential for organotypic structure formation and/ or TGFb-induced EMT, we exposed EpRas cells submerged within collagen gels to function-blocking antibodies against the a5 subunit, before and after TGFb-induced EMT. Antibodies against the a4 integrin subunit were used as controls. The latter neither interfered with the formation of branching, tubular structures in the absence of TGFb, nor with the reorganization of these structures into invasively growing strands and cords during TGFb-induced EMT (Figure 6b, bottom) . In contrast, EpRas cells treated with function-blocking anti-a5 antibodies failed to form visible structures (Figure 6b , top) rather than undergoing EMT. This was due to substantial induction of apoptosis as shown by TUNEL assay (Figure 6c ). As expected, the same function-blocking a5 antibodies had no effect on structure formation of parental EpH4 cells (data not shown), ruling out a general cytotoxic effect of the antibody used. Furthermore, the a5 antibody also failed to affect structure formation of fibroblastoid FibRas cells, a phenomenon previously observed with other agents that interfered with EMT (function-blocking antibodies to N-cadherin and PDGF, Beug et al., unpublished; Jechlinger et al., submitted).
In conclusion, expression of functional a5b1 is required during EMT, possibly protecting the cells from anoikis during EMT (Frisch and Ruoslahti, 1997), while they migrate within a mesenchymal ECM rather than adhering to epithelial-type basement membranes
FibRas cells do no longer deposit laminin 5
So far, our results did not explain why EpH4 cells showed a similarly strong binding to laminin 5 as EpRas and FibRas cells (see Figure 1 ). This could be due to the activity of a6b4 integrin, a major laminin 5 receptor. Since a6b4 is basolaterally expressed and connected to hemidesmosomes in fully polarized cells, we analysed whether expression of a6 would be altered or enhanced if EpH4 cells were allowed to form 'domes' or 'hemicysts' on tissue culture plastic, in which the cells are fully polarized. Interestingly, dome-forming EpH4 cells showed strong, lateral plasma-membrane expression of the a6 subunit, while surrounding cells remained essentially negative (Figure 7 ). This suggests that under these conditions, EpH4 cells express a6 mainly as a6b4 heterodimers, which may be implicated in basement membrane adhesion and in the establishment of epithelial cell polarity (Weaver et al., 2002) . It has to be taken into account, however, that in EpRas cells a6 was strictly laterally expressed, where it possibly contributed to cell-cell adhesion. Finally, the loss of polarized a6 expression and upregulation of a5b1/fibronectin deposition during Ras transformation and EMT prompted us to analyse ECM deposition of laminin 5 (the cognate a6b4 ligand) during Ras transformation of EpH4 cells and subsequent, TGFb1-induced EMT. ECMs formed on plastic by the different cell types were solubilized and analysed by Western blotting, employing the antibodies SE152 (recognizing the a3 subunit of laminin 5 and its 190 kDa precursor) and SE153 (recognizing the 105 kDa g2 subunit of laminin 5 and its 170 kDa mouse precursor).
These analyses revealed relatively weak matrix deposition of the processed a3 subunit of laminin 5 (running at 165 kDa) in EpH4 cells, relatively high levels of this subunit in the matrix of EpRas cells and no detectable deposition into FibRas matrices (Figure 8a) . Similarly, the mature laminin g2 subunit (105 kDa) and its 170 kD precursor were weakly deposited into EpH4 matrices, strongly in EpRas matrices and not at all in FibRas matrices (Figure 8b ). These results are in line with upregulation and functional activation of a6b4 in epithelial carcinoma cells (Rabinovitz and Mercurio, 1997) and with the idea that the dedifferentiated 'mesenchymal' FibRas cells generated during EMT switch to 'wounding' integrins like a6b1 and a5b1 for migration and invasion (see Discussion). integrin subunit prevent EMT of EpRas cells by inducing apoptosis. Cells were cultivated in 3D collagen gels for 24 h and then exposed to antibodies against the a5 integrin subunit (top panels) or, as a control, against the a4 integrin subunit (lower panel). After 4 days, 2 ng/ml TGFb1 was added (right panels) or not added (left panels). Photographs were taken after 8-10 days. Arrow, disordered structures of fibroblastoid, migratory cells formed after TGFb1 treatment; arrowheads, lumina in tubular structures formed by EpRas cells minus TGFb1; asterisk, dead cells. (c) Apoptosis induction by function-blocking a5 antibody was analysed in similar collagen gels as in (b), using a previously described in situ TUNEL assay (Materials and methods; Janda et al., 2002) . The values shown represent the mean of three independent determinations
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Discussion
Epithelial cells require careful regulation of both cell-cell adhesion and cell contacts to the ECM, in order to maintain epithelial tissue organization and epithelial cell function. In malignant cancer cells, adhesion molecules that mediate these interactions are frequently deregulated or compromised. We have previously shown that the expression and function of components of adherence junctions, like E-cadherin and b-catenin, are abrogated during EMT of mouse mammary epithelial cells (Oft et al., 1998; Janda et al., 2002) . In this report, we show that transformation by the Ha-Ras oncogene in nontumorigenic EpH4 mammary epithelial cells causes a significant upregulation of all the integrin subunits investigated (a2, a3, a5, a6 and b1). In line with this, EpRas cells show clearly increased cell adhesion to matrix proteins such as collagen types I/IV, fibronectin and laminin 1. In EpRas cells undergoing EMT in response to TGFb1, the integrin subunits a5, a6 and b1 were further upregulated and exposed in a depolarized manner on the entire cell surface. This allowed formation of a functional a5b1 fibronectin receptor on the resulting FibRas cells, which is crucially involved in EMT since function-blocking a5 antibodies specifically interfered with this process, causing apoptosis instead. The same antibody also inhibited migration of cells after EMT (FibRas) on plastic (Figure 4b ), but we could not determine the relevance of this migration inhibition for prevention of EMT due to the observed, strong apoptosis induction.
The factor centrally implicated in EMT is TGFb1, stabilizing the mesenchymal phenotype of FibRas cells by an autocrine TGFb1 loop. Autocrine TGFb1 induces and maintains the expression of new integrins in FibRas cells, such as the fibronectin receptor a5b1. According to others, integrin a5b1 is neither expressed in normal differentiated epithelia in vivo nor organized in defined adhesive structures in vitro (Pellegrini et al., 1992; Juhasz et al., 1993) . This suggests that a5b1 plays no important role in polarized epithelial cells tightly adhering to a basement membrane. Rather, integrins like a5b1 become expressed in certain 'emergency' situations, such as wounding or tumor development, during which basement membranes are destroyed and epithelial cells have to survive and migrate within or in close contact to a stromal environment (Saulnier et al., 1996) . Basement membrane disruption, per se, induces TGFb1 expression (Streuli et al., 1993) leading to increased production of ECM proteins, reformation of the basement membrane and downregulation of TGFb1 synthesis. However, in malignant tumors this feedback regulation between TGFb1 production and ECM protein deposition is disturbed. Tumor cells do not stop to produce TGFb1, which allows them to express a5b1, a prerequisite for cell migration. Our finding that a functional a5b1 integrin is indeed required for TGFb-induced EMT provides strong support for this notion, in line with findings by others (Putz et al., 1999; Reeves et al., 2001) . Interestingly, fibronectin receptors like a5b1 were also (Zuk and Hay, 1994) . A further important finding of this paper is that the a6 integrin subunit is subject to regulation during Ras transformation and EMT, both by upregulation in response to Ras and by delocalization to the entire plasma membrane during TGFb-induced EMT. While sparse, nonpolarized EpH4 cells hardly express subunit a6, it is strongly expressed in a lateral manner when EpH4 cells fully polarized in the so-called domes or hemicysts. In tumor-forming but still polarized EpRas cells, the a6 subunit is upregulated and expressed at the lateral membrane domain of all cells, suggesting that a6 contributes to the formation of cell-cell contacts. However, upon TGFb-induced cell conversion, the a6 subunit becomes exposed on the entire cell surface, allowing it to form functional a6b1 integrin, which together with a5b1 may enable these cells to adhere to proteolytically degrade and transmigrate the basement membranes of other tissues.
In contrast to EpRas cells, FibRas cells lack the ability to deposit laminin 5 into ECMs, a process requiring expression of the major laminin receptor a6b4. In line with this, laminin 5 expression was lost in invasive, dedifferentiated breast carcinomas (Henning et al., 1999) and dedifferentiated, E-cadherin-negative breast carcinoma cells (MDA-MB-231; Miller et al., 2001) . We thus assume that EMT abolishes formation or function of this integrin, which in polarized epithelial cells is restricted to cell-cell and cell-basement membrane contact areas and can be mobilized and activated during migration and local invasion of epithelial carcinoma cells after loss of polarity (O'Connor et al., 1998; Rabinovitz and Mercurio, 1997) . Instead, FibRas cells form the laminin receptor a6b1, which may allow them to bind to and migrate on or through basement membranes without restricting cell mobility. A respective switch between a6b4 and a6b1 was also implicated in malignant progression of human tumors (Harabayashi et al., 1999; Witkowski et al., 2000; Bogenrieder and Herlyn, 2003) . In line with this idea, function-blocking anti-b1 antibodies or b1 inhibitors reversed the malignant phenotype or caused apoptosis in a three-dimensional (3D) culture breast cancer model (Weaver et al., 1997) and in human tumor cells lines (Wang et al., 2002) . In contrast, antibodies interfering with the function of a6 or b4 integrin subunits expressed on nonmalignant breast epithelial cells induced continuous proliferation and disorganized 3D structures in collagen gels (Weaver et al., 1997 (Weaver et al., , 2002 .
In conclusion, our data allow to propose a speculative scenario how integrin-mediated adhesive and migratory behavior of Ras-transformed mammary epithelial cells may be altered during EMT, allowing the cells to invade and survive within a new stromal environment in 'emergency' situations such as tissue remodeling and malignant tumor progression. Our results suggest that one prerequisite for such changes is the TGFb-induced, delocalized surface expression of fibronectin receptors such as a5b1, also required for deposition of fibronectin and its bundling into fibers. In addition, the nonpolarized surface expression of the laminin receptor a6b1 on converted fibroblastoid cells might enable these to attach to and penetrate basement membranes. Its pericellular presence may thus be an important prerequisite for intra-and extravasation.
Materials and methods
Cell culture
In the present study, EpH4 cells and EpH4 cells expressing the viral Ha-Ras oncogene (EpRas) or the Ras effector loop mutants V12S35 and V12C40 have been employed (Oft et al., 1998; Janda et al., 2002) . While V12-Ras cells activate both the MAP kinase (MAPK) and the PI3 kinase (PI3K) pathways, V12S35 cells selectively signal along the MAPK pathway and V12C40 cells show basal MAPK signaling but exhibit elevated levels of PKB/Akt phosphorylation. Mesenchymal FibRas cells were derived from EpRas, which underwent EMT in vivo. Cells were subcultured twice a week and grown in DMEM supplemented with 4.5 g/ml sucrose, 8% fetal calf serum, 1% glutamine, 10 mM HEPES and antibiotics at 371C. In some experiments, EpRas cells were cultured in the presence of 8 ng/ ml recombinant TGFb1 (R&D Systems) or 50 mM MEK1 inhibitor PD98059 (Calbiochem, San Diego, CA, USA), respectively.
Antibodies
The rabbit polyclonal antibodies raised against the cytoplasmic domain of the a1, a2 and a3 integrin chains were a gift from P Defilippi (University of Torino; Defilippi et al., 1991) . The rabbit polyclonal antibody against the b1 subunit and the rat monoclonal antibody GoH3 against a6 were kindly supplied by S Johansson (University Uppsala, Sweden) and A Sonnenberg (Netherlands Cancer Institute, Amsterdam, The Netherlands), respectively. The rabbit polyclonal antibodies SE152 recognizing the a3 chain and SE153 detecting the g2 chain of murine laminin 5 were a kind gift from D Aberdam (Faculte´de Me´decine, Nice, France; Aberdam et al., 1994) . The rabbit polyclonal antibody L132 specific for laminin 5 was kindly provided by P Rousselle (IBCP, Lyon, France). Rabbit polyclonal anti-a5 and anti-fibronectin were obtained from Santa Cruz and Chemicon, respectively. Azide-free rat antimouse a4 (antibody R1-2) and a5 (antibody 5H10-27) integrin antibodies used in functional assays were from Pharmingen. The rabbit polyclonal b4 antibody was from Santa Cruz (sc-9090).
Adhesion assay
Tissue culture plates were coated overnight at 41C with fibronectin (Roche Diagnostics), rat tail collagen types I/IV (K Ku¨hn, Martinsried, Germany), laminin 1 (EHS-laminin, Sigma) and purified laminin 5 (5 mg/ml; P Rousselle, IBCP, Lyon, France). Liquid was removed and wells were further incubated (4 h) with 1% BSA. Mammary epithelial cells (5 Â 10 4 cells in 100 ml of serum-free medium) were then plated and allowed to adhere for 60 min at 371C. Cells were then washed with serum-free medium, fixed in 70% ethanol (10 min) and stained with 1% Crystal Violet (25 min). The wells were washed with tap water and stain was extracted from the cells with 50 ml 0.2% Triton X-100. Absorbance was quantified by reading at 550 nm.
Functional assays for integrin function in collagen gels
EpRas cells were cultured in 3D collagen gels as described (Oft et al., 1998) . Briefly, 1500 cells/100 ml collagen solution (1.4 mg/ml final concentration of rat tail collagen; Collaborative Biomedical Products) were seeded into four-well plates (Nunc). After 45 min of polymerization, mammary epithelial cell media (PromoCell) supplemented with TGFa, insulin, dexamethasone, isoproterenol and bovine pitutary extract (PromoCell) were added. Media were changed every 48 h. After structures had formed, antibodies to a5 integrin (5H10-27) or a4 integrin (R1-2) were added to the medium covering the collagen gels at 20 mg/ml. EMT was induced in 2-day-old gel structures by addition of TGFb1 (R&D Systems, 2 ng/ml). To measure apoptosis, collagen gels were fixed in 4% PFA/ PBS after 7 days, washed 3 Â with PBS and stained for apoptotic nuclei according to the supplier's instructions for the Cell Death Assay Kit (Roche). After staining, gels were washed with PBS, fixed with 4% PFA/250 mM HEPES, washed with PBST, permeabilized with 75% ethanol, counterstained with DAPI and evaluated for TUNEL-positive cells as described previously (Janda et al., 2002) .
Preparation of ECM
For matrix preparation, cells were allowed to reach confluency on plastic Petri dishes. Cells were detached with EDTA. The matrix was then washed several times in sterile PBS and solubilized in Laemmli sample buffer containing 2% b-mercaptoethanol at 951C. The solubilized matrix preparations were processed for SDS-PAGE on 6.5% resolving gels. Loading of matrix proteins was normalized to the number of each cell type at confluency.
In vitro wound healing assay
Wound healing assays were performed by plating cells on 3.5 cm diameter culture dishes in complete culture medium. At confluency, a wound was created using a blue pipet tip to scrape off the cells. The migration rate and the morphology of cells in the migration front during wound closure were monitored by phase-contrast microscopy. To analyse the role of a5b1 integrin heterodimers during wound closure, FibRas cells were incubated or not incubated with 20 mg/ml functionblocking anti-a5 antibody (5H10-27), in the presence or absence of 8 ng/ml TGFb1.
Northern blot analysis
Total mRNA (10 mg per lane) was denatured and separated by electrophoresis on agarose-formaldehyde gels as described (Wirl et al., 1995; Maschler et al., 2004) . Gels were blotted onto nylon membranes, which were probed with radiolabeled cDNAs encoding the a6 subunit (A Sonnenberg, Amsterdam, NL, USA). cDNA probes for GAPDH were used as loading control.
Western blot analysis
Cells were extracted in 250 ml RIPA buffer (50 mM Tris (pH 7.5), 150 mM NaCl, 1% SDS, 1 mM PMSF and 10 mg/ml aprotinin) on ice for 20 min. Supernatants were collected by centrifugation at 12 000 g and protein concentrations were determined using the Bio-Rad Protein Assay. SDS-PAGE on 7.5% gels was then performed with 40 mg of protein per lane under nonreducing conditions. Protein bands were transferred to nitrocellulose membranes (Hybond-ECL, Amersham), membranes were kept overnight at 41C in blocking solution (Tris-buffered saline, 5% dry milk) and incubated with antibody for 60 min in blocking solution. Membranes were processed using the enhanced chemiluminescence (ECL) system.
Surface labeling and immunoprecipitation
Cell surface biotinylation was performed detaching confluent cells with trypsin-EDTA. Cell suspensions were washed in Hank's balanced salt solution and biotinylation was achieved by adding 1.0 mg/ml Sulfo-NHS-Biotin (Sigma) for 15 min at 41C with gentle rotation (Defilippi et al., 1997) . Biotinylation was stopped by washing three times in DMEM, which contained 0.6% bovine serum albumin (BSA). Cells were extracted for 20 min at 41C in 500 ml of 50 mM Tris (pH 7.5), 0.1% Triton-X-100, 150 mM NaCl and protease inhibitors. Extracts were centrifuged and used for protein determination. Equal amounts (1 mg) of protein were immunoprecipitated with 2 ml of antibody in a total of 200 ml solution for 16 h at 41C. A measure of 20 ml of protein A-sepharose was added to each reaction and incubation was continued for 2 h. Precipitates were processed for SDS-PAGE under nonreducing conditions. Biotinylated proteins were detected by incubation for 30 min with streptavidin-horse radish peroxidase and exposed to luminol substrate. Co-immunoprecipitation of a6 and b1 integrin subunits was performed by using a polyclonal rabbit a6 antibody (Santa Cruz). Briefly, equal amounts (400 mg) of protein were immunoprecipitated with 10 ml of a6 antibody in a total of 200 ml solution over night. A measure of 20 ml of protein A/G-sepharose was added. After 2 h incubation, precipitates were processed for SDS-PAGE. The b1 integrin subunit was detected by Western blotting with a polyclonal b1 antibody.
FACS analysis
For FACS analysis, cells were harvested by trypsinization, washed with PBS containing 1% FBS and incubated with 1 mg anti-a5 antibody/10 6 cells in 100 ml volume (PBS with 1% FBS) for 1 h at 41C. After washing three times in PBS plus 1% FBS and counterstaining with 1 mg/ml propidium iodide, cells were analysed on a FACS Vantage and data processed using Cell Quest software (Becton Dickinson).
Immunohistochemistry
Cells were fixed for 20 min in 4% PFA in PBS (containing 1 mM CaCl 2 and 2 mM MgCl 2 ). Thereafter, they were permeabilized for 2 min with 0.1% Triton X-100 in PBS. Polyclonal antibodies against the b1, a2, a3 and a5 subunits and monoclonal antibodies against the a6 chain were employed. Immunofluorescence was visualized using a Carl Zeiss LSM 410 UV confocal laser scanning microscope. For fibronectin matrix staining, cells were fixed with 4% PFA, and incubated with the FN antibody without permeabilization.
